AYALA PHARMACEUTICALS, INC.: accounts_payable
| Value | {"amount": 5555279, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2016-04-30) |
| Status | current |
| Entity | AYALA PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:01:28.181425+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/319be2e2-4f7d-403e-8048-c0665850e643
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001493152-16-010602 · Open the official SEC filing →Retrieved: 2026-08-19T11:01:28.181425+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001100397/accounts-payable/2016-04-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/319be2e2-4f7d-403e-8048-c0665850e643
History
- no predecessors — first report